Flevy Management Insights Case Study
Operational Efficiency Strategy for Pharma Company in North America


Fortune 500 companies typically bring on global consulting firms, like McKinsey, BCG, Bain, Deloitte, and Accenture, or boutique consulting firms specializing in Hoshin to thoroughly analyze their unique business challenges and competitive situations. These firms provide strategic recommendations based on consulting frameworks, subject matter expertise, benchmark data, KPIs, best practices, and other tools developed from past client work. We followed this management consulting approach for this case study.

TLDR A leading pharma company experienced a 20% rise in operational costs and a 15% drop in productivity due to regulatory changes and generic competition. They adopted Hoshin Planning and utilized advanced analytics and Six Sigma, achieving a 15% cost reduction and a 20% productivity boost. This underscores the value of Strategic Planning and continuous improvement in overcoming operational challenges.

Reading time: 10 minutes

Consider this scenario: A leading pharmaceutical company in North America is confronted with a strategic challenge requiring a comprehensive hoshin planning approach.

It faces a 20% increase in operational costs coupled with a 15% decline in productivity, exacerbated by stringent regulatory changes and heightened competition from generic drug manufacturers. Additionally, internal challenges such as outdated technology and process inefficiencies are undermining its competitive edge. The primary strategic objective of the organization is to enhance operational efficiency and reduce costs to improve profitability and maintain its market position.



The organization, a prominent player in the pharmaceutical sector, is at a critical juncture. The rising operational costs and decreasing productivity signal deeper systemic issues, possibly rooted in outdated technology and inefficient processes. These challenges are further compounded by the external pressures of regulatory changes and the competitive threat posed by generic drug manufacturers.

Strategic Planning

The pharmaceutical industry is currently experiencing significant transformations, driven by regulatory changes, advances in biotechnology, and shifts in healthcare policies.

Understanding the competitive landscape is crucial for strategic positioning. The industry's dynamics can be assessed by evaluating:

  • Internal Rivalry: Competition among established pharmaceutical companies is intensifying, with firms competing on innovation, drug efficacy, and market access strategies.
  • Supplier Power: Suppliers of raw materials and proprietary drug components wield moderate power, given the stringent quality requirements and regulatory compliance needed.
  • Buyer Power: The power of buyers, including hospitals, pharmacies, and health insurance companies, is increasing, pushing for lower drug prices and cost-effective treatment options.
  • Threat of New Entrants: Although the pharmaceutical industry has high barriers to entry due to regulatory and capital requirements, biotech startups and generic drug manufacturers pose a significant threat.
  • Threat of Substitutes: The threat of substitutes is moderate but growing, with alternative therapies and generic drugs gaining market acceptance.

Emerging trends indicate a shift towards personalized medicine, digital health solutions, and sustainable manufacturing practices. These trends necessitate major changes in:

  • Adoption of digital health technologies, offering opportunities for innovation in drug development and patient care but requiring significant investment in technology and skills training.
  • Increasing regulatory scrutiny, presenting risks in compliance costs and market access but also opportunities for companies that can navigate these complexities effectively.
  • Shift towards sustainable manufacturing, which can improve brand image and reduce long-term costs, but requires upfront investment in green technologies.

A STEEPLE analysis reveals that socio-demographic shifts towards an aging population, technological advancements in drug discovery and patient care, and evolving legal frameworks around drug approval and patent laws are key factors influencing the industry.

For a deeper analysis, take a look at these Strategic Planning best practices:

Strategic Planning: Process, Key Frameworks, and Tools (79-slide PowerPoint deck)
Strategic Planning: Hoshin Kanri (Hoshin Planning) (153-slide PowerPoint deck)
Best Practices in Strategic Planning (23-slide PowerPoint deck)
Strategic Planning - Hoshin Policy Deployment (138-slide PowerPoint deck)
Market Analysis and Competitive Positioning Assessment (45-slide PowerPoint deck)
View additional Hoshin best practices

Are you familiar with Flevy? We are you shortcut to immediate value.
Flevy provides business best practices—the same as those produced by top-tier consulting firms and used by Fortune 100 companies. Our best practice business frameworks, financial models, and templates are of the same caliber as those produced by top-tier management consulting firms, like McKinsey, BCG, Bain, Deloitte, and Accenture. Most were developed by seasoned executives and consultants with 20+ years of experience.

Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab

Internal Assessment

The company possesses a strong portfolio of patented drugs and a robust distribution network, but is hampered by outdated technology and process inefficiencies.

A MOST analysis indicates that the company's mission to lead in innovative pharmaceutical solutions is challenged by operational inefficiencies. Its strategic objectives are being undermined by outdated operational processes and a lack of technology adoption, highlighting a gap between its ambitions and its operational capabilities.

A Value Chain analysis shows strengths in research and development and distribution but identifies significant gaps in operations, particularly in manufacturing and supply chain management, which are areas ripe for improvement.

The Gap Analysis underscores the urgent need for the company to modernize its technology infrastructure and streamline its operational processes to close the gap between its current performance and its strategic objectives.

Strategic Initiatives

  • Implementation of Advanced Analytics for Process Optimization: Deploy advanced analytics in manufacturing and supply chain operations to identify inefficiencies and optimize processes. The goal is to reduce operational costs by 15% and improve productivity by 20%. The value creation lies in enhancing process efficiency and reducing waste. This initiative requires investment in analytics technology and training for staff.
  • Adoption of Digital Health Technologies: Integrate digital health technologies into drug development and patient engagement strategies. This aims to accelerate drug development cycles and improve patient outcomes. The initiative is expected to open new revenue streams and strengthen the company's competitive position. It necessitates investment in digital technologies and partnerships with tech companies.
  • Hoshin Kanri for Strategic Alignment: Implement a Hoshin Kanri process to ensure that strategic objectives are effectively communicated and executed across the organization. This will align operations with strategic goals, improving operational efficiency and strategic coherence. This initiative requires the establishment of a cross-functional team and training in Hoshin Kanri principles.

Hoshin Implementation KPIs

KPIS are crucial throughout the implementation process. They provide quantifiable checkpoints to validate the alignment of operational activities with our strategic goals, ensuring that execution is not just activity-driven, but results-oriented. Further, these KPIs act as early indicators of progress or deviation, enabling agile decision-making and course correction if needed.


What you measure is what you get. Senior executives understand that their organization's measurement system strongly affects the behavior of managers and employees.
     – Robert S. Kaplan and David P. Norton (creators of the Balanced Scorecard)

  • Operational Cost Reduction: A key metric to measure the effectiveness of process optimization initiatives.
  • Drug Development Cycle Time: Decreasing cycle time will indicate success in leveraging digital health technologies for faster drug development.
  • Strategic Alignment Score: An assessment of how well operational activities align with the strategic objectives post-Hoshin Kanri implementation.

These KPIs will provide insights into the efficacy of the strategic initiatives, highlighting areas of success and those requiring further attention to ensure the strategic objectives are met.

For more KPIs, take a look at the Flevy KPI Library, one of the most comprehensive databases of KPIs available. Having a centralized library of KPIs saves you significant time and effort in researching and developing metrics, allowing you to focus more on analysis, implementation of strategies, and other more value-added activities.

Learn more about Flevy KPI Library KPI Management Performance Management Balanced Scorecard

Stakeholder Management

Successful implementation of the strategic initiatives depends on the active involvement and support from both internal and external stakeholders, including R&D teams, IT departments, regulatory bodies, and health care providers.

  • Employees: Crucial for adopting new processes and technologies.
  • IT Department: Responsible for implementing analytics and digital health technologies.
  • Regulatory Bodies: Key external stakeholders influencing market access and compliance.
  • Health Care Providers: Partners in patient engagement and adoption of digital health solutions.
  • Patients: The ultimate beneficiaries of improved drug development and personalized care.
Stakeholder GroupsRACI
Employees
IT Department
Regulatory Bodies
Health Care Providers
Patients

We've only identified the primary stakeholder groups above. There are also participants and groups involved for various activities in each of the strategic initiatives.

Learn more about Stakeholder Management Change Management Focus Interviewing Workshops Supplier Management

Hoshin Best Practices

To improve the effectiveness of implementation, we can leverage best practice documents in Hoshin. These resources below were developed by management consulting firms and Hoshin subject matter experts.

Hoshin Deliverables

These are a selection of deliverables across all the strategic initiatives.

  • Operational Efficiency Improvement Plan (PPT)
  • Digital Health Integration Roadmap (PPT)
  • Advanced Analytics Implementation Framework (PPT)
  • Strategic Alignment Assessment Report (PPT)
  • Investment and ROI Analysis Model (Excel)

Explore more Hoshin deliverables

Implementation of Advanced Analytics for Process Optimization

The team employed the Resource-Based View (RBV) framework to guide the strategic initiative of implementing advanced analytics for process optimization. The RBV framework, which focuses on leveraging a company's internal resources as a source of competitive advantage, proved invaluable. It highlighted the importance of the company's data assets and analytical capabilities as key resources. The team then proceeded with the following steps:

  • Conducted an inventory of existing data assets and analytical tools to assess the company's current capabilities.
  • Identified gaps in the company's data infrastructure and analytics expertise that could hinder the effective use of advanced analytics for process optimization.
  • Implemented targeted training programs to enhance the analytics skills of the workforce and invested in upgrading the data infrastructure to support advanced analytics applications.

Additionally, the team applied the Six Sigma framework to the process optimization initiative. Six Sigma provided a structured methodology for identifying, analyzing, and improving existing business processes to reduce waste and increase efficiency. Following Six Sigma, the team:

  • Mapped out all key operational processes to identify variability and inefficiencies that could be targeted for improvement.
  • Utilized advanced analytics to perform root cause analysis on the identified process inefficiencies.
  • Developed and implemented process improvements and monitored the outcomes to ensure sustained efficiency gains.

The combination of the Resource-Based View and Six Sigma frameworks significantly enhanced the company's process optimization efforts. By leveraging its internal resources effectively and applying a rigorous process improvement methodology, the company achieved a 15% reduction in operational costs and a 20% improvement in productivity. These results underscored the effectiveness of the strategic initiative and the value of the chosen frameworks in guiding its implementation.

Adoption of Digital Health Technologies

For the strategic initiative focusing on the adoption of digital health technologies, the team utilized the Diffusion of Innovations (DOI) theory. DOI theory, which explains how, why, and at what rate new ideas and technology spread, was instrumental in understanding the adoption lifecycle of digital health technologies within the organization. By examining the characteristics of digital health innovations, including their relative advantage, compatibility, complexity, trialability, and observability, the team could strategize the rollout effectively. They executed the following actions:

  • Evaluated the relative advantage of proposed digital health technologies over existing processes and tools, highlighting benefits such as improved patient outcomes and accelerated drug development cycles.
  • Assessed the compatibility of new digital health technologies with existing systems and workflows, making necessary adjustments to ensure a seamless integration.
  • Conducted pilot programs for selected digital health technologies to assess their trialability and gather feedback for further refinement.

Consequently, the implementation of digital health technologies led to enhanced drug development processes and improved patient engagement strategies. The strategic use of DOI theory enabled the organization to navigate the complexities of technology adoption, resulting in new revenue streams and a strengthened competitive position in the market.

Hoshin Kanri for Strategic Alignment

The deployment of Hoshin Kanri for achieving strategic alignment within the organization was guided by the Objectives and Key Results (OKR) framework. OKR is a goal-setting framework used to define and track objectives and their outcomes. It was particularly useful in this context because it complemented the Hoshin Kanri process by ensuring that strategic objectives were measurable and closely monitored. Following the OKR framework, the team:

  • Identified the key strategic objectives for the organization that aligned with the overall vision and mission.
  • Set specific, measurable, achievable, relevant, and time-bound (SMART) key results for each objective to track progress and execution.
  • Established a regular review process to assess progress against the key results and make necessary adjustments to the strategic initiatives.

The successful implementation of Hoshin Kanri, supported by the OKR framework, resulted in a more aligned organization where strategic objectives were effectively communicated and executed across all levels. This strategic initiative significantly improved operational efficiency and strategic coherence, demonstrating the power of combining Hoshin Kanri with OKR to achieve comprehensive strategic alignment.

Additional Resources Relevant to Hoshin

Here are additional best practices relevant to Hoshin from the Flevy Marketplace.

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

Key Findings and Results

Here is a summary of the key results of this case study:

  • Reduced operational costs by 15% through the implementation of advanced analytics for process optimization.
  • Improved productivity by 20% by leveraging Six Sigma methodologies in operational processes.
  • Enhanced drug development processes and patient engagement strategies through the adoption of digital health technologies.
  • Generated new revenue streams and strengthened competitive position by integrating digital health solutions.
  • Achieved comprehensive strategic alignment across the organization with the implementation of Hoshin Kanri supported by the OKR framework.

The strategic initiatives undertaken by the pharmaceutical company have yielded significant results, notably in reducing operational costs and improving productivity, which directly address the company's initial challenges of rising operational costs and declining productivity. The successful implementation of advanced analytics and Six Sigma methodologies has demonstrated the value of leveraging internal resources and applying rigorous process improvement methodologies. However, while the adoption of digital health technologies has opened new revenue streams, the quantifiable impact on the company's market position vis-à-vis generic drug manufacturers remains unclear. This suggests that while the company has made strides in innovation and patient engagement, the competitive threat from generics requires ongoing attention. Additionally, the successful strategic alignment through Hoshin Kanri and OKR frameworks is commendable, but the long-term sustainability of these changes will depend on continuous monitoring and adaptation to external market forces.

Given the results and the analysis, the recommended next steps should focus on consolidating the gains achieved through operational efficiencies and digital health technologies while addressing areas of less clear impact. Specifically, the company should conduct a detailed market analysis to better understand the competitive landscape with generic drug manufacturers and explore strategic partnerships or acquisitions to bolster its market position. Furthermore, to sustain the strategic alignment and operational efficiencies achieved, it is recommended to establish a permanent cross-functional team dedicated to continuous improvement and innovation, ensuring the company remains agile and responsive to market changes.

Source: Operational Efficiency Strategy for Pharma Company in North America, Flevy Management Insights, 2024

Flevy is the world's largest knowledge base of best practices.


Leverage the Experience of Experts.

Find documents of the same caliber as those used by top-tier consulting firms, like McKinsey, BCG, Bain, Deloitte, Accenture.

Download Immediately and Use.

Our PowerPoint presentations, Excel workbooks, and Word documents are completely customizable, including rebrandable.

Save Time, Effort, and Money.

Save yourself and your employees countless hours. Use that time to work on more value-added and fulfilling activities.




Read Customer Testimonials




Additional Flevy Management Insights

Hoshin Planning Improvement for a Multinational Tech Firm

Scenario: A multinational technology firm has been struggling with its current Hoshin Planning approach, which is seen as lacking alignment between strategic objectives and daily operational tasks.

Read Full Case Study

Strategic Hoshin Planning for a Semiconductor Firm

Scenario: The organization, a semiconductor company, has been facing significant challenges in aligning its operational efforts with strategic objectives.

Read Full Case Study

Hoshin Kanri Strategic Planning Facilitation for a High-Growth Tech Firm

Scenario: A rapidly expanding tech organization found itself grappling with aligning strategic objectives across all departmental levels.

Read Full Case Study

Strategic Policy Deployment for Maritime Shipping Leader

Scenario: The organization is a prominent player in the maritime shipping industry, facing challenges in aligning its expansive global operations with corporate strategy.

Read Full Case Study

Hoshin Kanri Alignment for Maritime Transportation Leader

Scenario: A leading firm in the maritime transportation sector is struggling to align its operational activities with strategic objectives.

Read Full Case Study

Strategic Hoshin Planning in Power & Utilities

Scenario: A firm in the power and utilities sector is struggling to align its strategic objectives with operational activities using Hoshin Planning.

Read Full Case Study

Hoshin Kanri Strategy Deployment for Retail Chain in Competitive Landscape

Scenario: A retail firm is grappling with aligning its strategic objectives with operational activities across its extensive chain of stores.

Read Full Case Study

Digital Transformation Strategy for Finance and Insurance Brokerage Firm

Scenario: A prominent finance and insurance brokerage firm is facing strategic challenges in adapting to the digital era, requiring a comprehensive Hoshin planning approach.

Read Full Case Study

Luxury Travel Firm's Strategic Alignment Initiative in Boutique Lodging

Scenario: The organization in question operates within the luxury travel and boutique lodging sector, facing challenges in aligning its long-term strategic goals with operational activities.

Read Full Case Study

Hoshin Kanri Deployment for Elite Sports Franchise

Scenario: A top-tier sports franchise is struggling to align its long-term strategic goals with daily operations, an issue exacerbated by recent expansions and diversifications into new markets.

Read Full Case Study

Policy Deployment Strategy for Luxury Retailer in European Market

Scenario: The organization in question is a high-end luxury retailer operating in the European market that has recently expanded its product lines and entered new markets.

Read Full Case Study

Strategic Hoshin Kanri Alignment for IT Services Firm in Renewable Energy

Scenario: An IT services firm specializing in renewable energy solutions is facing challenges aligning its strategic goals with operational execution.

Read Full Case Study

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S Strategy Model, Balanced Scorecard, Disruptive Innovation, BCG Experience Curve, and many more.